Skip to content

Income Taxes Payable at other companies

Eli Lilly logo
Eli LillyLLY
$5.29B-14.4%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.54M
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%
Enterprise value$1.29B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's income taxes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's income taxes payable?
MoonLake Immunotherapeutics (MLTX) reported income taxes payable of $1.4M in Q1 2026.
How has MoonLake Immunotherapeutics's income taxes payable changed year-over-year?
MoonLake Immunotherapeutics's income taxes payable decreased by 37.5% year-over-year, from $2.23M to $1.4M.
What is the long-term trend for MoonLake Immunotherapeutics's income taxes payable?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's income taxes payable has grown at a 103.4% compound annual growth rate (CAGR), from $63.92K to $1.09M.
What does income taxes payable mean?
Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.